ARCHIVES

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

ELM Wins ACCC Management Contract Over ORC, Others

February 21, 1992

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 14, 2000

ACS Forms Foundation To Handle Large Gifts

September 4, 1992

Leukemia Society Program In Transitional Research.

January 14, 2000

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990